Member Info for DShox

Grrrr

Hi chap. Yes, all good and hope you're doing well also! Remember we enjoyed the hospitality of Mr Burton at TMS with JAN and HMI some years back.

Igraine RNS tells us the work following prelim results will be 'drilling down' into each individual using lab analysis but this will not stop commercial deal negotiations. Why drill down and talk about concurrent deal negotiations if AZD is a pile of ****?

Igraine seems to have gone in for the deal execution risk more than the drug meeting safety/efficacy targets in my view. I mean, Igraine bought barely 1 month before the trial ended.

Just read that - noted Igraine bought its interest in June when much of the data would be in and the language used is indicative of success.

Don't sell your tickets here if you can afford to hold subject all personal tolerances etc. Far too much value inflection bubbling away.

Maybe. Generally agree that poor results would be long known and capable of timely RNS. Investors must be optimistic or why buy a single VELA share - so glass half full, hopefully we get 'a result' here.

Revisit to day high. Ready for next move.

This is Phase II results outcome. Anyone know the route to global patient use from there? I appreciate SGS et al intend to 'commercialise' immediately but where does max value occur?

Robbo the RNSs there do suggest that as of July, there was positive indication of trial success.

Whether its Twitter's Clint or as I re-badged him, Clunt, before blocking the idiot, or toothless members of TWs little gang, let this be a lesson to you all.

Agree. MMs have enough stock to control price. It'll only be day traders that wanted a free FOMO trade upset. I quite like the liquidity.

Lucyd will have a Beats moment.

Pretty good spin for those odds. I suspect successful outcome sends it to a multibag as speculation swirls on VELA exit value. Cash to the bottom line of a company like VELA makes alot of difference to share price and ability to support existing investments. I for one noted the warrants enabled an investor to accumulate in what otherwise would have been an illiquid stock. I suspect the draw of imminent possibility of a substantial value accretion event will pull in more investors tomorrow rather than activity on Twitter.

MMs wont allow a rise with news pending and warrant flips. No risk free ride before results day. It is de-risked and high potential so long as you recognise clinical trial outcomes are complicated affairs.

Was NT to buy £2k at 30p

Forget TA, theres limited stock, not enough sellers, fundamental increase in value and tiny market cap.

4 v 1 L2
Expect traders to take out 2.05 in short order

Rampky :)

Pumpky is little optimistic on HEMO but ultimately, market must wait for RNSs to re-evaluate.

Shedding zero shares

We are building up to main event

Soon back over 30p

Just washing out a few traders